Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DB26FV3Y8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,869
Award facts
- Contract value 100% obligated
- $2,869.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded November 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of 36,000 units of Creon DR 100 capsules, a pancreatic enzyme replacement therapy, with a ceiling value of $2,869.12. The award is non-competitive and was made without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where the performance will occur, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare systems.
The contract utilizes firm fixed-price pricing and is scheduled for ultimate completion by November 13, 2025. As a child contract under the DLA Troop Support Medical IDC, this delivery order reflects AmerisourceBergen's ongoing role in supplying specialty medications and pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems. The DLA Troop Support is developing successor Pharmaceutical Prime Vendor Global Program Generation V contracts anticipated to involve multiple regional awards, positioning AmerisourceBergen to continue serving as a key provider for military and government healthcare pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DB26FV3Y8?
SPE2DB26FV3Y8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FV3Y8 worth?
The government has obligated $2,869 on SPE2DB26FV3Y8.
Is contract SPE2DB26FV3Y8 an order under another contract?
Yes. SPE2DB26FV3Y8 is a delivery order under SPE2DB20D3104, an indefinite delivery contract.
Was contract SPE2DB26FV3Y8 competed?
The extent of competition for SPE2DB26FV3Y8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award